Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinoma

スポンサーリンク

概要

論文の詳細を見る
2008-06-10

著者

関連論文

Botulinum neurotoxin type A in urology : Antibodies as a cause of therapy failure
Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma
Internal validation of an artificial neural network for prostate biopsy outcome
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinoma
Acucise endopyelotomy : A technique with limited efficacy for primary ureteropelvic junction obstruction in adults
Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer
Neoadjuvant therapy of renal cell carcinoma : A novel treatment option in the era of targeted therapy?
Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter study
Clinical judgment is the most important element in overhydration assessment of chronic hemodialysis patients

スポンサーリンク